Searched for
LUPIN SUBSIDIARY ACQUISITION
Lupin subsidiary inks pact to acquire Netherlands-based VISUfarmaLupin's subsidiary will acquire VISUfarma BV for 190 million euros. This expands Lupin's European business and eye health product range. Th...- Lupin acquires UK-based firm for 12.3 million poundsLupin has acquired UK-based Renascience Pharma for £12.3 million, enhancing its branded medicine portfolio. The acquisition allows Lupin to...
- Lupin subsidiary acquires 9 brands South African firmLupin's subsidiary, in partnership with ImpiloVest, has acquired nine brands from MNI in South Africa, enhancing its portfolio in complemen...
- Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 crLupin has acquired a portfolio of established products in Europe and Canada from Sanofi for a purchase consideration of EUR 10 million. The...
- Lupin inks pact to acquire 5 drug brands from Menarini for Rs 101 croreLupin said it has inked a pact to acquire five drug brands from Italian firm Menarini for Rs 101 crore. The company has signed an agreement...
- Lupin acquires Australia's Southern Cross PharmaAs a part of the transaction, Lupin's Australia subsidiary Generic Health will gain access to over 60 registered products having sales of o...
- Lupin to acquire Australia-based Southern Cross PharmaGeneric Health, the Australia based wholly-owned subsidiary of Lupin, has entered into a definitive agreement under which Lupin will acquir...
- Lupin looks to sell Japanese arm Kyowa for $600 millionKyowa grew a modest 5% over the year-ago level. Its net profit halved to Rs 68.6 crore constituting 11.3% of Lupin’s consolidated profit. "...
- Lupin gains on Symbiomix Therapeutics acquisitionThe scrip touched its fresh 52-week high of Rs 1,572.25 on February 6, 2017 and its 52-week low of Rs 920 on August 21, 2017.
- Lupin's US arm takes over Symbiomix TherapeuticsLupin had entered into an arrangement to acquire the company earlier this year.
- Lupin to beef up branded portfolio through alliances and strategic brand acquisitionsLupin is looking at strengthening its branded portfolio by creating alliances and eyeing strategic brand acquisitions in US markets in 2015...
- Lupin completes acquisition of Mexico's Laboratories GrinMexico is one of the fastest growing pharmaceutical markets in the world valued at over $ 13.5 billion and growing at 9-10% annually.
- Lupin eyes growth via strategic brand acquisitions in United StatesLupin Ltd is looking at strengthening branded portfolio with the launch of additional products developed and filed with the USFDA from its ...
- Lupin aims to double sales in Japan to $500 million in next 5 yearsDrug firm Lupin is targeting to double sales in Japan to $500 million (over Rs 2,600 crore) in the next five years on the back of enhanced ...
- Lupin to replicate Japan model for expansion in various marketsLupin recently enhanced its presence in Japan with the acquisition of I'rom Pharmaceuticals in November this year for an undisclosed amount.
- Lupin eyes USD 300 mn revenues from Japan in next 2 yearsDrug maker Lupin is eyeing a jump of over 80 per cent in its revenues to $300 million (about Rs 1,557 crore) from the Japanese market in th...
- Lupin targets buys in Gulf, Mexico, Brazil and ArgentinaLupin Ltd. continues its buying spree with planned acquisitions in Gulf, Mexico, Brazil and Argentina.
- Inorganic engine drives Lupin’s generic growthMumbai-based Lupin has been aggressively using the inorganic route to expand its cross-border generic business.
- Lupin close to speciality pharma buy in AmericaDrug maker Lupin plans to acquire a speciality pharmaceutical company in the United States to expand its portfolio of brands in the paediat...
- Lupin acquires pharma business of RubaminDrug maker Lupin Ltd on Thursday said it has acquired the pharmaceutical business of Rubamin group, for an undisclosed amount.
Load More
